Coronary obstruction registry after TAVI

There is little information in the literature about the obstruction of the coronary ostia after percutaneous aortic valve implantation. 81 TAVI sites and programs and 6688 patients in total provided information on this complication. Of all, 28 patients (0.66%) developed this complication, being more frequent for balloon-expandable prosthesis and when procedures were performed “valve in valve“. In these patients, intraoperative death was 15.9% and in-hospital death was 40.9%. 81.8% could be treated by angioplasty

Conclusion: damage of the coronary ostia during TAVI is rare and is associated with high morbi-mortality.

henrique_ribeiro_europcr
Henrique Ribeiro
2013-05-23

Original title: Coronary Obstruction following Transcatheter Aortic Valve Implantation (TAVI) in High risk patients. Multicenter Registry.

 

More articles by this author

Clinical results of TAVI in Asia

Since all the studies available in the literature were conducted in North America or Europe, the results of percutaneous aortic valve replacement in Asia...

RIPCORD study: FFR changes clinical consideration of chest pain

The objective of this study was to evaluate whether routine use of FFR in all the coronary arteries could change the strategy in stable...

Coherex Wave Crest: New device for atrial appendage closure

Appendage closure devices have emerged as an alternative to anticoagulation in fibrillated patients with a contraindication for it. The study included 63 patients with...

PATA – STEMI: thromboaspiration correlates with a lower index of microcirculatory resistance

Routine manual vacuum in patients with acute coronary syndrome and ST-segment elevation improves myocardial perfusion according to non-invasive parameters. Invasive assessment of microcirculation has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....